Towards an individualised target concentration of adalimumab in rheumatoid arthritis

被引：25

作者：

Ducourau, Emilie ^{[1
,2
]}

Ternant, David ^{[1
,3
]}

Lequerre, Thierry ^{[4
,5
,6
]}

Fuzibet, Piera ^{[1
,2
]}

Le Loet, Xavier ^{[4
,5
,6
]}

Watier, Herve ^{[1
,7
]}

Goupille, Philippe ^{[1
,2
]}

Paintaud, Gilles ^{[1
,3
]}

Vittecoq, Olivier ^{[4
,5
,6
]}

Mulleman, Denis ^{[1
,2
]}

机构：

[1] Univ Tours, CNRS, UMR 7292, Tours, France

[2] CHRU Tours, Serv Rhumatol, F-37044 Tours 9, France

[3] CHRU Tours, Lab Pharmacol Toxicol, F-37044 Tours 9, France

[4] Univ Rouen, INSERM, U905, Rouen, France

[5] CIC CRB0204, Rouen, France

[6] CHRU Rouen, Serv Rhumatol, Rouen, France

[7] CHRU Tours, Immunol Lab, F-37044 Tours 9, France

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷 / 07期

关键词：

ANTIBODIES;

D O I：

10.1136/annrheumdis-2013-204971

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1427 / 1428

页数：2

共 6 条

[1] Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients [J].

Aletaha, Daniel ;

Funovits, Julia ;

Keystone, Edward C. ;

Smolen, Josef S. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (10) :3226-3235

[2] Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis [J].

Bartelds, Geertje M. ;

Wijbrandts, Carla A. ;

Nurmohamed, Michael T. ;

Stapel, Steven ;

Lems, Willem F. ;

Aarden, Lucien ;

Dijkmans, Ben A. C. ;

Tak, Paul Peter ;

Wolbink, Gerrit Jan .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :921-926

[3] Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept [J].

Blache, Celine ;

Lequerre, Thierry ;

Roucheux, Arnaud ;

Beutheu, Stephanie ;

Dedreux, Ingrid ;

Jacquot, Serge ;

Le Loet, Xavier ;

Boyer, Olivier ;

Vittecoq, Olivier .

RHEUMATOLOGY, 2011, 50 (10) :1814-1822

[4] Fitting Emax models to clinical trial dose-response data [J].

Kirby, Simon ;

Brain, Phil ;

Jones, Byron .

PHARMACEUTICAL STATISTICS, 2011, 10 (02) :143-149

[5] Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis? [J].

Mulleman, Denis ;

Ducourau, Emilie ;

Paintaud, Gilles ;

Ternant, David ;

Watier, Herve ;

Goupille, Philippe .

JOINT BONE SPINE, 2012, 79 (02) :109-112

[6] Key findings towards optimising adalimumab treatment: the concentration-effect curve [J].

Pouw, Mieke F. ;

Krieckaert, Charlotte L. ;

Nurmohamed, Michael T. ;

van der Kleij, Desiree ;

Aarden, Lucien ;

Rispens, Theo ;

Wolbink, Gertjan .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) :513-518

← 1 →